EXHIBIT
        31.2
 
 CERTIFICATION  OF
        CHIEF
        FINANCIAL  OFFICER  PURSUANT TO
        SECURITIES  EXCHANGE ACT
 RULES
        13A-14 AND 15D-14 AS ADOPTED
        PURSUANT TO SECTION 302 OF THE
 SARBANES-OXLEY ACT
        OF 2002
 
 In
        connection  with the Form 10-QSB/A of Biomoda,  Inc. for the
        quarter ended June  30,  2007
        (the  "quarterly  report")  as
        filed  with the  Securities  and Exchange  Commission
        on the date hereof, I John J Cousins as President and Chief Financial
        Officer of the Company, certify that:
 
 1.
        I have
        reviewed this  quarterly  report on Form 10-QSB/A of
        Biomoda,  Inc. (the "registrant");
 
 2.
        Based
        on
        my  knowledge,  this  quarterly  report  does
        not contain any untrue statement
        of a material fact or omit to state a material fact  necessary to make the
        statements made, in light of the  circumstances  under which
        such statements were
        made,  not  misleading  with respect to the period
        covered by his quarterly report;
 
 3.  Based  on  my  knowledge,  the  financial  statements  and  other  financial information  included
        in this quarterly  report,  fairly present in all material respects
        the financial  condition,  results of
        operations  and cash flows of the registrant
        as of, and for the periods presented in this quarterly report;
 4.
        I am
        responsible for  establishing  and
        maintaining  disclosure  controls and procedures  (as
        defined in Exchange Act
        rules  13a-15(e)  and  15d-15(e) for the registrant
        and have:
 
 a.  Designed such disclosure controls
        and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to
        the registrant,  including its consolidated subsidiary is made known
        to us by
        others within those entities, particularly during the
        period in which
        this quarterly report is being prepared;
 
 b.
        Evaluated the effectiveness of the registrant's disclosure
        controls and
        procedures and presented in this quarterly report
        our conclusions about
        the effectiveness of the disclosure controls and procedures as of the end
        of the period covered by this report based on such evaluation; and
 
 c.  Disclosed  in
        this report any change in
        the  registrant's  internal control
        over financial  reporting that occurred during the
        registrant's most
        recent fiscal quarter (the  registrant's fourth fiscal quarter in the
        case
        of an  annual  report)  that
        has  materially affected, or is reasonably likely
        to materially affect, the registrant's internal control
        over financial reporting;
 
 5.
        I
        have  disclosed,  based on our most
        recent  evaluation of internal  control over
        financial  reporting,  to
        the  registrant's  auditors and the  registrant's board
        of
        directors (or persons performing the equivalent functions);
 
 a.
        All significant  deficiencies in the design or operation of
        internal controls  which  could  adversely  affect
        the  registrant's  ability to record,
        process, summarize and report financial information; and
 
 b.
        Any fraud,  whether or
        not  material,  that  involves  management
        or other  employees  who  have
        a  significant  role  in  the  registrant's internal
        control over financial reporting.


Biomoda, Inc.January
                    4,
                    2008
              By:
              /s/ John
                J
                CousinsJohn
                J CousinsPresident
&
                Chief Financial Officer